Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
Regression Toward the Mean01:52

Regression Toward the Mean

6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

226
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
226
Cancer Survival Analysis01:21

Cancer Survival Analysis

630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning-based ranking method for subgroup and predictive biomarker identification in patients.

Communications medicine·2025
Same author

BioPred: an R package for biomarkers analysis in precision medicine.

Bioinformatics (Oxford, England)·2024
Same author

Analysis of the inheritance pattern of a Chinese family with phaeochromocytomas through whole exome sequencing.

Gene·2013
Same author

Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.

Journal of medicinal chemistry·2013
Same author

Sequential [3 + 2] and [4 + 2] cycloadditions for stereoselective synthesis of a novel polyheterocyclic scaffold.

ACS combinatorial science·2013
Same author

VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.

Reproductive biology and endocrinology : RB&E·2013

Related Experiment Video

Updated: Jan 9, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Explaining Individualized Treatment Rules: Integrating LIME and SHAP With Xgboost in Precision Medicine.

Zihuan Liu1, Xin Huang1

  • 1Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA.

Statistics in Medicine
|December 2, 2025
PubMed
Summary

This study enhances precision medicine by integrating interpretable models. It uses permutation tests and explanation techniques (LIME, SHAP) to identify treatment effect heterogeneity and improve individualized treatment rules (ITR).

Keywords:
Shapley valuecausal machine learningmodel interpretabilitypermutation testpredictive biomarker

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

Area of Science:

  • Computational biology
  • Biostatistics
  • Precision medicine

Background:

  • Precision medicine requires interpretable predictive models for individualized treatments.
  • Extreme gradient boosting (XGBoost) offers high predictive accuracy but lacks interpretability.
  • Understanding feature influence is crucial for identifying patient subgroups and biomarkers.

Purpose of the Study:

  • To develop an interpretable framework for estimating individualized treatment rules (ITR) using XGBoost.
  • To assess treatment effect heterogeneity using a global permutation test.
  • To enhance model interpretability using Local Interpretable Model-agnostic Explanations (LIME) and SHAPley Additive exPlanations (SHAP).

Main Methods:

  • Developed a permutation-based pipeline within an XGBoost framework for ITR estimation.
  • Incorporated LIME and SHAP for model-agnostic interpretability at global and individual levels.
  • Validated the approach through simulations and real-world clinical trial data analysis.

Main Results:

  • The permutation-based pipeline successfully detected empirical signals of treatment effect heterogeneity.
  • LIME and SHAP provided valuable exploratory insights into feature contributions to ITR.
  • The integrated framework demonstrated improved understanding of complex predictive models in clinical settings.

Conclusions:

  • The proposed framework enhances the interpretability of XGBoost models for precision medicine.
  • It enables robust identification of treatment effect heterogeneity, guiding individualized treatment strategies.
  • Combining permutation tests with LIME and SHAP offers a powerful approach for advancing precision medicine research.